4//SEC Filing
Van Trump Phillip D 4
Accession 0001213900-20-045829
CIK 0001779020other
Filed
Dec 30, 7:00 PM ET
Accepted
Dec 31, 6:09 PM ET
Size
17.7 KB
Accession
0001213900-20-045829
Insider Transaction Report
Form 4
Van Trump Phillip D
Chief Science & Tech.
Transactions
- Award
Stock Option
2020-12-29+549,480→ 549,480 totalExercise: $3.28Exp: 2026-06-30→ Common Stock (549,480 underlying) - Award
Stock Option
2020-12-29+71,249→ 71,249 totalExercise: $3.28Exp: 2026-06-30→ Common Stock (71,249 underlying) - Award
Stock Option
2020-12-29+247,266→ 247,266 totalExercise: $3.28Exp: 2027-12-18→ Common Stock (247,266 underlying) - Award
Class A Common Stock ("Common Stock")
2020-12-29+22,894→ 22,894 total - Award
Stock Option
2020-12-29+91,580→ 91,580 totalExercise: $6.88From: 2023-09-01Exp: 2030-09-01→ Common Stock (91,580 underlying) - Award
Stock Option
2020-12-29+642,934→ 642,934 totalExercise: $24.20Exp: 2030-12-29→ Common Stock (642,934 underlying)
Footnotes (5)
- [F1]Received in exchange for shares of common stock of Meredian Holdings Group, Inc., a Georgia corporation ("MHG") pursuant to the Agreement and Plan of Merger, dated as of October 3, 2020, by and among Live Oak Acquisition Corp., a Delaware corporation ("Live Oak"), Green Merger Corp., a Georgia corporation and wholly owned subsidiary of Live Oak ("Merger Sub"), MHG, Live Oak Sponsor Partners, LLC, as representative for Live Oak, and John A. Dowdy, Jr., as representative of the shareholders of the Company, as amended by Amendment No. 1, dated as of October 8, 2020, and Amendment No. 2, dated as of December 11, 2020, by and among all the parties thereto (as amended, the "Merger Agreement"), pursuant to which MHG became a direct, wholly-owned subsidiary of Live Oak, which subsequently changed its name to Danimer Scientific, Inc. (the "Issuer").
- [F2]The options are fully vested and currently exercisable.
- [F3]Received pursuant to the Merger Agreement in exchange for stock options to purchase shares of MHG common stock.
- [F4]Options to purchase 214,311 shares of Common Stock will vest and become exercisable on or after December 29, 2021 if the closing price of a share of Common Stock equals or exceeds $14.00 for any twenty (20) trading dates within a thirty (30)-day trading period beginning on December 29, 2021, options to purchase 214,311 shares of Common Stock will vest and become exercisable on or after December 29, 2022 if the closing price of a share of Common Stock equals or exceeds $17.00 for any twenty (20) trading dates within a thirty (30)-day trading period beginning on December 29, 2021 and options to purchase 214,312 shares of Common Stock will vest and become exercisable on or after December 29, 2023 if the closing price of a share of Common Stock equals or exceeds $20.00 for any twenty (20) trading dates within a thirty (30)-day trading period beginning on December 29, 2021.
- [F5]Granted pursuant to the terms of the Merger Agreement and issued under the Plan.
Documents
Issuer
Danimer Scientific, Inc.
CIK 0001779020
Entity typeother
Related Parties
1- filerCIK 0001837808
Filing Metadata
- Form type
- 4
- Filed
- Dec 30, 7:00 PM ET
- Accepted
- Dec 31, 6:09 PM ET
- Size
- 17.7 KB